Related Experiment Video
Updated: Jul 18, 2026
![Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58491.jpg&w=3840&q=50)
Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
Published on: August 8, 2019
The control of bone remodeling by neuropeptide Y receptors
S J Allison1, P A Baldock, H Herzog
1Bone and Mineral Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, 384 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia.
Abstract:
An important role for the neuropeptide Y receptor system in the regulation of bone formation was recently revealed with a significant elevation in trabecular bone formation and bone volume following germline or hypothalamus-specific deletion of neuropeptide Y2 receptors in mice. Subsequent studies have now demonstrated that this central pathway is distinct from that of the other centrally regulated bone formation pathway mediated by leptin. This review discusses these recent findings and outlines how these new pathways could translate into potential novel targets for the treatment of bone disease.
Insights
Deleting neuropeptide Y2 receptors boosts bone formation by affecting the central nervous system. This newly identified pathway is separate from the leptin pathway, offering new therapeutic targets for bone diseases.
Area of Science:
- Neuroendocrinology
- Bone Biology
- Metabolic Regulation
Background:
- The neuropeptide Y (NPY) system plays a role in energy homeostasis and has been implicated in bone metabolism.
- Previous research suggested a link between NPY and bone formation, but the specific receptors and pathways were unclear.
Purpose of the Study:
- To review recent findings on the role of the neuropeptide Y receptor system in regulating bone formation.
- To elucidate the central mechanisms by which NPY influences bone metabolism.
- To explore the potential of NPY pathways as therapeutic targets for bone diseases.
Main Methods:
- Germline and hypothalamus-specific deletion of neuropeptide Y2 receptors in mouse models.
- Analysis of trabecular bone formation and bone volume.
- Comparison with known centrally regulated bone formation pathways, such as the leptin pathway.
Main Results:
- Deletion of neuropeptide Y2 receptors led to a significant increase in trabecular bone formation and bone volume.
- The identified NPY pathway regulating bone formation is distinct from the leptin-mediated pathway.
- These findings highlight a novel central regulatory mechanism for bone metabolism.
Conclusions:
- The neuropeptide Y receptor system, particularly neuropeptide Y2 receptors, is crucial for regulating bone formation.
- A novel central pathway distinct from leptin signaling controls bone metabolism via NPY.
- Targeting these NPY pathways presents a promising strategy for developing new treatments for bone diseases like osteoporosis.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair
Regulation of Food Intake
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
